Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 767.760
- +10.220+1.35%
Close Dec 20 16:00 ET
- 780.990
- +13.230+1.72%
Post 20:01 ET
728.85BMarket Cap83.00P/E (TTM)
811.350High766.610Low9.94MVolume811.350Open757.540Pre Close7.81BTurnover1.05%Turnover Ratio132.37P/E (Static)949.32MShares970.91652wk High51.18P/B727.28BFloat Cap563.94552wk Low5.03Dividend TTM947.28MShs Float970.916Historical High0.66%Div YieldTTM5.91%Amplitude5.278Historical Low785.311Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- --
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Alonzo Weems
- Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Jacob S. Van Naarden
- Executive Vice President and President, Loxo
- 4.89M
- Ilya Yuffa
- Executive Vice President and President, Lilly International
- --
- Eric Dozier
- Executive Vice President, Human Resources and Diversity
- --
- Johna L. Norton
- Executive Vice President, Global Quality
- --
- Patrik Jonsson
- Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
- --
- Ralph Alvarez
- Independent Director
- 336.00K
- Jamere Jackson
- Independent Director
- 345.00K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Karen Walker
- Independent Director
- 359.00K
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Katherine Baicker
- Independent Director
- 336.00K
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
- Jon R. Moeller
- Independent Director
- --
- Jon Erik Fyrwald
- Independent Director
- 344.88K
